A Physician Attack on the FDA—Will the Supreme Court Reduce Access to Mifepristone?

( N Engl J Med . 2024;390(6);563–567. doi: 10.1056/NEJMms2312012.) In 1965, Ms R. traveled from Denver to have a legal abortion in Japan due to concerns about an illegal US abortion being unsafe. Today, more than 80% of women who get abortions are 11 weeks pregnant or less, and as such, may legally take abortion medication (mifepristone and misoprostol pills) at home. However, options will become much more limited if the Supreme Court decides in favor of antiabortion physicians who have sued the Food and Drug Administration (FDA) to revoke its approval and regulation of mifepristone.

Authors

Institutions

Publication Details

Journal
Obstetric Anesthesia Digest
Published
2024-08-23
DOI
https://doi.org/10.1097/01.aoa.0001026488.05320.02
Primary Topic
Pharmaceutical industry and healthcare
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Physician Attack on the FDA—Will the Supreme Court Reduce Access to Mifepristone?

Debra Malina, Katie Watson
Obstetric Anesthesia Digest
Pharmaceutical industry and healthcare
article

A Physician Attack on the FDA—Will the Supreme Court Reduce Access to Mifepristone?

Debra Malina, Katie Watson
article en

Abstract

( N Engl J Med . 2024;390(6);563–567. doi: 10.1056/NEJMms2312012.) In 1965, Ms R. traveled from Denver to have a legal abortion in Japan due to concerns about an illegal US abortion being unsafe. Today, more than 80% of women who get abortions are 11 weeks pregnant or less, and as such, may legally take abortion medication (mifepristone and misoprostol pills) at home. However, options will become much more limited if the Supreme Court decides in favor of antiabortion physicians who have sued the Food and Drug Administration (FDA) to revoke its approval and regulation of mifepristone.

Obstetric Anesthesia DigestVol. 44(3)
Northwestern University (US)
Good health and well-being
Openalex Percentile: Top 82%
Pharmaceutical industry and healthcare
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A Physician Attack on the FDA—Will the Supreme Court Reduce Access to Mifepristone? — Debra Malina, Katie Watson · Obstetric Anesthesia Digest (2024) | TGRS Research Map | TGRS